Hologic’s latest update keeps its fair value estimate steady at about US$76.60 per share, signaling no change to the headline price target in current analyst models. That stability comes as research ...
What Hologic’s Recent Performance Signals for Investors Hologic (HOLX) has drawn fresh attention after a period of steady share moves, with the stock recently closing at US$75.36. That price sits ...
Zacks Investment Research on MSN
Here is what to know beyond why Hologic, Inc. (HOLX) is a trending stock
Hologic (HOLX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...
Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
Hologic campaign wants women to stop ‘suffering in silence’ for their disruptive period symptoms
Women’s health tech company Hologic is launching "Better is Possible," a new health education and awareness campaign aimed at getting women to talk to their doctors about their disruptive period ...
Marlborough-based medical device manufacturer Hologic has been issued a warning letter from the U.S. Food and Drug Administration concerning its BioZorb Marker, a device originally recalled in March.
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Med-tech company Hologic raised its annual sales forecast on Thursday, on the back of strong demand for its ...
Hologic’s HOLX Molecular Diagnostics business posted a 7.8% (excluding COVID-19-related sales) growth in the second quarter of fiscal 2025, although results did not reflect its full potential.The ...
As Hologic gears up to cease operations at its Danbury, Connecticut facility in December, the Marlborough-based medical device manufacturer plans tol incrementally lay off 86 employees by the end of ...
On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions ...
Hologic has been outperforming peers but underperforming the broader medical device sector, with shares up about 5% since my last analysis. Fiscal Q3 results showed consistent beats in Diagnostics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results